Eisai and Biogen Launch LEQEMBI® for Early Alzheimer's Treatment in South Korea

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusett...

November 28, 2024 | Thursday | News
Halozyme Withdraws €2.0 Billion Acquisition Proposal for Evotec Amid Lack of Engagement

Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme" or the "Company") announced it has withdrawn its non-binding proposal to acquire Evotec SE (NASDAQ: ...

November 25, 2024 | Monday | News
BioNTech Acquires Biotheus to Strengthen Oncology Pipeline with Bispecific Antibody Asset BNT327/PM8002

BioNTech SE (Nasdaq: BNTX, “BioNTech”) and Biotheus (“Biotheus”) announced the signing of a definitive agreement for...

November 14, 2024 | Thursday | News
Lars Fruergaard Jørgensen Announces 21% Surge in Novo Nordisk’s Operating Profit, Driven by Strong Demand for Diabetes and Obesity Treatments

 Financial report for the period 1 January 2024 to 30 September 2024                      &nb...

November 06, 2024 | Wednesday | Company results
Syndax Pharmaceuticals Secures $350 Million Synthetic Royalty Funding Agreement with Royalty Pharma for Niktimvo™

Syndax Pharmaceuticals (Nasdaq: SNDX) and Royalty Pharma plc (Nasdaq: RPRX) announced that Syndax has entered into a $350 million synth...

November 05, 2024 | Tuesday | News
Ate Therapeutics Grants 16,400 Restricted Stock Units to New Employees

Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripot...

November 04, 2024 | Monday | News
Norman Schwartz Announces Bio-Rad’s Q3 Sales of $649.7 Million with 3.4% Currency-Neutral Growth, Driven by Clinical Diagnostics

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products,  announced financial r...

October 31, 2024 | Thursday | Company results
PL Developments Secures FDA Approval for Omeprazole OTC and Successfully Refinances Corporate Debt

PL Developments (PLD), a leader in the development, manufacturing, packaging, and distribution of consumer healthcare products, announced two significant m...

October 29, 2024 | Tuesday | News
Two Australian Scientists Awarded CSL Centenary Fellowships to Advance Cancer Research

 Two Australian scientists have each been awarded CSL Centenary Fellowships, valued at $1.25 million over five years. The Fellowships were presented ...

October 25, 2024 | Friday | News
Grifols Partners with BARDA to Develop Eye Drops for Sulfur Mustard Ocular Injury

Grifols (MCE:GRF, MCE:GRF.P, NASDAQ:GRFS), a global healthcare company and leading manufacturer of plasma-derived medicines, announced it has established a...

October 23, 2024 | Wednesday | News
Symbiosis Expands with £1.2M Barclays-Financed Acquisition of New 20,000 Sq/Ft Stirling Facility to Boost High-Tech Medicine Production

    Symbiosis acquires a 20,000 sq/ft building in Stirling, UK, to house new high-tech medicines manufacturing capacity, financed by £1...

October 09, 2024 | Wednesday | News
Singular Genomics Receives $12.00 Per Share Acquisition Proposal from Concentra Biosciences

Singular Genomics Systems, a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and cli...

September 20, 2024 | Friday | News
EQT Private Capital Asia Acquires Controlling Stake in GeBBS Healthcare Solutions to Drive Global Expansion

GeBBS Healthcare Solutions ("GeBBS" or the "Company") specializes in revenue cycle management, health information management (HIM),...

September 09, 2024 | Monday | News
Nxera Pharma to Receive $35 Million Milestone Payment from Neurocrine Following Successful Phase 2 Schizophrenia Trial

Nxera Pharma Co – formerly known as Sosei Group or Sosei Heptares – announces that it will receive a US$35 million payment from Neurocrine Bi...

September 03, 2024 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close